vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and HARROW, INC. (HROW). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $75.1M, roughly 1.2× SAUL CENTERS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs 7.4%, a 1.2% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 10.6%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 6.2%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
BFS vs HROW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $89.1M |
| Net Profit | $6.5M | $6.6M |
| Gross Margin | — | 79.3% |
| Operating Margin | 65.4% | 17.5% |
| Net Margin | 8.7% | 7.4% |
| Revenue YoY | 10.6% | 33.3% |
| Net Profit YoY | -19.6% | -2.2% |
| EPS (diluted) | $0.15 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $89.1M | ||
| Q3 25 | $72.0M | $71.6M | ||
| Q2 25 | $70.8M | $63.7M | ||
| Q1 25 | $71.9M | $47.8M | ||
| Q4 24 | $67.9M | $66.8M | ||
| Q3 24 | $67.3M | $49.3M | ||
| Q2 24 | $66.9M | $48.9M | ||
| Q1 24 | $66.7M | $34.6M |
| Q4 25 | $6.5M | $6.6M | ||
| Q3 25 | $10.5M | $1.0M | ||
| Q2 25 | $10.7M | $5.0M | ||
| Q1 25 | $9.8M | $-17.8M | ||
| Q4 24 | $8.1M | $6.8M | ||
| Q3 24 | $14.5M | $-4.2M | ||
| Q2 24 | $14.4M | $-6.5M | ||
| Q1 24 | $13.6M | $-13.6M |
| Q4 25 | — | 79.3% | ||
| Q3 25 | — | 75.3% | ||
| Q2 25 | — | 74.5% | ||
| Q1 25 | — | 67.5% | ||
| Q4 24 | — | 78.8% | ||
| Q3 24 | 73.6% | 75.6% | ||
| Q2 24 | 74.2% | 74.4% | ||
| Q1 24 | 72.8% | 69.5% |
| Q4 25 | 65.4% | 17.5% | ||
| Q3 25 | 69.1% | 20.6% | ||
| Q2 25 | 68.7% | 17.9% | ||
| Q1 25 | 66.5% | -23.5% | ||
| Q4 24 | 82.9% | 19.3% | ||
| Q3 24 | 72.8% | 2.7% | ||
| Q2 24 | 75.0% | 3.1% | ||
| Q1 24 | 72.4% | -20.0% |
| Q4 25 | 8.7% | 7.4% | ||
| Q3 25 | 14.6% | 1.4% | ||
| Q2 25 | 15.1% | 7.8% | ||
| Q1 25 | 13.6% | -37.2% | ||
| Q4 24 | 11.9% | 10.1% | ||
| Q3 24 | 21.5% | -8.6% | ||
| Q2 24 | 21.6% | -13.2% | ||
| Q1 24 | 20.4% | -39.2% |
| Q4 25 | $0.15 | $0.20 | ||
| Q3 25 | $0.32 | $0.03 | ||
| Q2 25 | $0.33 | $0.13 | ||
| Q1 25 | $0.29 | $-0.50 | ||
| Q4 24 | $0.22 | $0.19 | ||
| Q3 24 | $0.48 | $-0.12 | ||
| Q2 24 | $0.48 | $-0.18 | ||
| Q1 24 | $0.45 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $72.9M |
| Total DebtLower is stronger | $468.4M | $250.0M |
| Stockholders' EquityBook value | $307.8M | $52.4M |
| Total Assets | $2.2B | $399.5M |
| Debt / EquityLower = less leverage | 1.52× | 4.77× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $72.9M | ||
| Q3 25 | $11.8M | $74.3M | ||
| Q2 25 | $5.3M | $53.0M | ||
| Q1 25 | $6.5M | $66.7M | ||
| Q4 24 | $10.3M | $47.2M | ||
| Q3 24 | $7.2M | $72.6M | ||
| Q2 24 | $6.9M | $71.0M | ||
| Q1 24 | $7.1M | $76.0M |
| Q4 25 | $468.4M | $250.0M | ||
| Q3 25 | $1.6B | $347.2M | ||
| Q2 25 | $1.6B | $250.6M | ||
| Q1 25 | $1.5B | $256.9M | ||
| Q4 24 | $455.8M | $262.7M | ||
| Q3 24 | $1.5B | $230.7M | ||
| Q2 24 | $1.4B | $236.3M | ||
| Q1 24 | $1.4B | $243.4M |
| Q4 25 | $307.8M | $52.4M | ||
| Q3 25 | $316.6M | $47.0M | ||
| Q2 25 | $322.4M | $49.7M | ||
| Q1 25 | $328.4M | $56.5M | ||
| Q4 24 | $335.8M | $69.7M | ||
| Q3 24 | $341.8M | $58.0M | ||
| Q2 24 | $345.7M | $58.5M | ||
| Q1 24 | $347.1M | $60.6M |
| Q4 25 | $2.2B | $399.5M | ||
| Q3 25 | $2.2B | $363.1M | ||
| Q2 25 | $2.1B | $345.0M | ||
| Q1 25 | $2.1B | $364.2M | ||
| Q4 24 | $2.1B | $389.0M | ||
| Q3 24 | $2.1B | $351.5M | ||
| Q2 24 | $2.1B | $306.6M | ||
| Q1 24 | $2.0B | $295.5M |
| Q4 25 | 1.52× | 4.77× | ||
| Q3 25 | 5.02× | 7.39× | ||
| Q2 25 | 4.85× | 5.05× | ||
| Q1 25 | 4.70× | 4.55× | ||
| Q4 24 | 1.36× | 3.77× | ||
| Q3 24 | 4.37× | 3.98× | ||
| Q2 24 | 4.17× | 4.04× | ||
| Q1 24 | 4.06× | 4.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $8.4M |
| Free Cash FlowOCF − Capex | — | $8.1M |
| FCF MarginFCF / Revenue | — | 9.1% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | 15.35× | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $8.4M | ||
| Q3 25 | $20.6M | $16.6M | ||
| Q2 25 | $26.6M | $-803.0K | ||
| Q1 25 | $30.4M | $19.7M | ||
| Q4 24 | $121.2M | $-17.8M | ||
| Q3 24 | $26.5M | $3.0M | ||
| Q2 24 | $32.1M | $-2.7M | ||
| Q1 24 | $33.8M | $-4.6M |
| Q4 25 | — | $8.1M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $-969.0K | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $-18.3M | ||
| Q3 24 | $-28.3M | $2.3M | ||
| Q2 24 | $-12.5M | $-3.1M | ||
| Q1 24 | $-11.7M | $-4.7M |
| Q4 25 | — | 9.1% | ||
| Q3 25 | — | 22.9% | ||
| Q2 25 | — | -1.5% | ||
| Q1 25 | — | 40.8% | ||
| Q4 24 | — | -27.4% | ||
| Q3 24 | -42.1% | 4.8% | ||
| Q2 24 | -18.7% | -6.3% | ||
| Q1 24 | -17.6% | -13.6% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | 81.5% | 1.2% | ||
| Q2 24 | 66.7% | 0.7% | ||
| Q1 24 | 68.3% | 0.3% |
| Q4 25 | 15.35× | 1.27× | ||
| Q3 25 | 1.97× | 16.26× | ||
| Q2 25 | 2.48× | -0.16× | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | 14.98× | -2.62× | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
